Skip to main content
| News

What we learned at this year’s DayOne Conference

19.10.2019

DayOne Conference 2019

Twenty-two panellists and speakers, among them 3 patients and digital health futurist Maneesh Juneja, 30 project champions and their mentors, 40 volunteers and 450 participants and Arcondis as conference Partner  — this was the DayOne Conference which took place on September 9 at the FHNW in Muttenz.

It is fair to say that the format, now in its fourth edition, has established itself, even though change in terms of location and order of events has been and will most probably continue to be constant, given the mission of DayOne to shape the future of health. What will remain are the basic ingredients – a growing community of healthcare innovators and their appetite to share their expertise and co-create with their peers.

Representing the vibrant healthcare ecosystem of the Basel region and beyond, the DayOne innovation community is attracting ever more entrepreneurs to attend the open innovation session at the conference; the session includes both applicants to the DayOne accelerator program and also ventures and projects for which feedback is sought. This big collaborative effort makes the DayOne Conference unique, even for entrepreneurs from abroad.

Also unique to the DayOne Conference is the openness to talk about neglected issues. One of these is – strangely enough for this industry – the need to include the patient’s view. In fact, the conference started and set the tone with a patients’ panel, followed by a session on future ethics in healthcare and a session on financing innovation – beyond venture capital.

The following are our personal takeaways from this year’s DayOne Conference:

1) Patient centricity is key: Even though starting with the patients seems the most obvious in healthcare innovation, there still seems to be considerable reluctance to accept this concept. The patient stories on stage clearly showed the necessity: As technology evolves, allowing new ways for patients to monitor and more efficiently (self)manage their health states, new applications will only succeed if they bring tangible value to end-users and improve their quality of life.

2) No trust, no business: Trust in technology is becoming a crucial factor for advancing innovation. Ethics therefore matter. Patients and individuals will only share their data for a good reason and if they get something out of it. In the long run, Health Data Ecosystems, the foundation of healthcare innovation, will not thrive in an environment of unilateral enforcement and exploitation.

3) De-risking investment through collaboration: Regarding the investments flowing into Digital Health, Europe seems to be losing out between the superpowers of the east (China) and west (USA). However, money cannot buy everything. What bright minds need most of all is innovation ecosystems where their ideas can be nourished and validated, providing access to healthcare providers and industry. Thus, building on a strong collaborative effort between stakeholders will stimulate entrepreneurial appetite and de-risk investments.

4) Entrepreneurs need diversity: Technology is there and ready to use. A key differentiator for digital health start-ups is the ability to make the best use of it. This requires a culture of integrating diverse capabilities, such as data sciences, medicine, research, patient/user experience and also commercialisation. In this respect, DayOne hubs with their community approach are becoming increasingly crucial for business creation.

(This report hast been co-authored by Manuel Kammermann, Arcondis)

A huge thank you for everyone who made this year’s DayOne Conference happen!

Canton of Basel-Stadt and BaselArea.swiss for facilitating. Our Conference Partner: Arcondis. 

The Patients: Cecile Tardy, Judith Safford, Peter Loewenberg

The Speakers and Panellist on Ethics: Nicholetta Iacobacci, Exponential Ethics; Evelyne Bischof, Shanghai Jiao Tong University School of Medicine; Bram Stieltjes, Universitätsspital Basel; Daniel R. Karlin, HealthMode; Athula Herath, Novartis; Erik Schkommodau, FHNW

The Speakers and on Financing: Andreas Igel, Arcondis; Julien de Salaberry, Galen Growth; Alex Buech, Medical Insights; Jan Vichr, Canopei; Sybille Fischer, Baloise; Gabor Szinnai, UKBB; Stephanie Bova, Takeda; Amine Korchi, Fusion; André Guedel, KPMG

Keynote: Maneesh Juneja, Digital Health Futurist, London

Moderation and Curation: Thomas Brenzikofer and Doug Häggström

Open Innovation Head Coaches: Aurelie Moser, Viktor Bullain, Egle B. Thomas

30 Projects Champions, their mentors and 40 Volunteers

And to our DayOne Conference supporting partners: MedInside, Swiss Healthcare Startups, CSEM, ETH Zürich- DBSSE, FHNW, Swiss Institute of Bioinformatics, Swiss TPH, UKBB, Universität Basel, Universitätsspital Basel, ELCA, SAS, Soladis Group

See the presentations

Check out the project’s work

Background read on the Future of Health 

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

South Korean pharma firms show interest in the Basel Area
Basel Area Business & Innovation, Invest, Life Sciences / biotech, Switzerland Innovation Park

South Korean pharma firms show interest in the Basel Area

Several South Korean firms from the life sciences industry, including three pharmaceutical multinationals, have visited the Basel Area on fact-finding...

Read More
Gamma Technologies acquires ProFEMAG portfolio
Advanced Manufacturing/AI, Basel Area Business & Innovation, ICT, Innovation, Invest

Gamma Technologies acquires ProFEMAG portfolio

The Basel-based firm ProFEMAG AG has sold its FEMAG software for electrical machine applications to Gamma Technologies. The company based...

Read More
Databaum establishes headquarters in Basel
Basel Area Business & Innovation, ICT, Innovation, Invest, Life Sciences / biotech

Databaum establishes headquarters in Basel

Databaum is establishing its headquarters in Basel and plans to grow from its location there. The startup provides the agricultural...

Read More
Clinerion launches patient information platform
Basel Area Business & Innovation, Digital Health, ICT, Innovation, Invest, Life Sciences / biotech

Clinerion launches patient information platform

Basel-based Clinerion is introducing its machine learning platform. It comprises a global network of hospitals and enables researchers to recognize...

Read More
New innovation campus opens in the Basel Area
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech, Switzerland Innovation Park

New innovation campus opens in the Basel Area

The Main Campus of the Switzerland Innovation Park Basel Area was officially opened on October 29. In his speech, Federal...

Read More
Sumitovant acquires all shares in Myovant
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Sumitovant acquires all shares in Myovant

Sumitovant is in the process of making Basel-based Myovant Sciences a wholly owned subsidiary by acquiring a 100 percent shareholding...

Read More
VectivBio raises 125 million US dollars in stock sale
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

VectivBio raises 125 million US dollars in stock sale

VectivBio has announced the closing of the subscription offer for 16,700,000 ordinary shares. The Basel-based biotechnology firm has generated gross...

Read More
KetoSwiss secures capital increase of 4 million dollars
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

KetoSwiss secures capital increase of 4 million dollars

KetoSwiss has banked a total of 4 million US dollars from investors. The Basel-based startup develops products to alleviate neurological...

Read More
Escientia Switzerland becomes Primopus
Basel Area Business & Innovation, Invest, Life Sciences / biotech

Escientia Switzerland becomes Primopus

The Indian company Deccan Fine Chemicals is acquiring Escientia Switzerland and renaming it as Primopus AG. The new owner announces...

Read More
Novartis investing 100 million Swiss francs in new biologics center
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Novartis investing 100 million Swiss francs in new biologics center

The pharmaceutical company Novartis is investing a sum of 100 million Swiss francs in a new competence center for biologics...

Read More
1 2 3 18

Do you have a question? We'd like to hear from you.